NCT04335695 is a NA clinical trial of Vascular Rehabilitation in Vascular Diseases, sponsored by Baylor Research Institute.

Who is sponsoring NCT04335695?

NCT04335695 is sponsored by Baylor Research Institute.

What drugs are being tested in NCT04335695?

Interventions in NCT04335695: Vascular Rehabilitation.

What condition does NCT04335695 study?

NCT04335695 studies Vascular Diseases, Peripheral Artery Disease, Peripheral Vascular Diseases.

Is NCT04335695 still recruiting?

NCT04335695 is currently terminated. Last updated 14 October 2022.

Last reviewed 2022-10-14 · How we verify

NCT04335695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life

Terminated NA Last updated 14 October 2022

What this trial tests

NA trial testing Vascular Rehabilitation in Vascular Diseases in 7 participants. Terminated before completion.

Timeline

13 December 2019

Primary endpoint
24 January 2022

24 January 2022

Quick facts

Lead sponsor	Baylor Research Institute
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	7
Start date	13 December 2019
Primary completion	24 January 2022
Estimated completion	24 January 2022
Sites	1 location across United States

Drugs / interventions tested

Vascular Rehabilitation

Conditions studied

Vascular Diseases — all drugs for Vascular Diseases →
Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Peripheral Vascular Diseases — all drugs for Peripheral Vascular Diseases →

Sponsor

Baylor Research Institute

Who can join

18 and older, any sex, with Vascular Diseases or Peripheral Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to identify the type of patients being referred for the Vascular Rehabilitation Program (VRP) and to study the success rates of the program according to improvements in walking distance and quality of life surveys. Subjects will be in the VRP for 6-12 weeks and then be followed for 12 months after they complete the program. This is a single-site study at Baylor Scott \& White Heart Hospital-Plano.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vascular Diseases

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Baylor Research Institute trials

Trials by the same sponsor.

NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
NCT07547878 — Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · not yet recruiting
NCT07460583 — ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes · NA · not yet recruiting
NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04335695 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
Last refreshed: 14 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing